Death activation does not stop tumor growth: Quantitative evidence for concomitant activation of apoptosis in tumor growth in vitro

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 807-818

  Watanabe, Hideomi ^a   Shinozaki, Tetsuya ^a   Shiba, Shunsuke ^a   Suzuki, Hideki ^a   Takagishi, Kenji ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cell cycle; P34(cdc2); P53; Tumor growth

Indexed keywords

DNA FRAGMENT; PROTEIN P53;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DEATH; DNA CLEAVAGE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

EID: 0031669785     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.807     Document Type: Article

References (65)

1. Fesus L, Davies PJA and Piacentini M: Apoptosis: molecular mechanisms in programmed cell death. Eur J Cell Biol 56: 170-177, 1991.
2. Kerr JFR, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26:239-257, 1972.
3. Raff MC: Social controls on cell survival and cell death. Nature 356:397-400, 1992.
4. Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 90:786-789, 1992.
5. Wyllie AH, Kerr JFR and Currie AR: Cell death: the significance of apoptosis. Int Rev Cytol 68:251-306, 1980.
6. Wyllie AH: The biology of cell death in tumours. Anticancer Res 5:131-136, 1985.
7. Wyllie AH: Apoptosis (The 1992 Frank Rose Memorial Lecture). Br J Cancer 67: 205-208, 1993.
8. Sarraf CE and Bowen ID: Proportions of mitotic and apoptotic cells in a range of untreated experimental tumours. Cell Tissue Kinet 21:45-49, 1988.
9. Williams GT: Programmed cell death: apoptosis and oncogenesis. Cell 65:1097-1098, 1988.
10. Jiang C, Lu J, Garcia G and Thompson HJ: Spontaneous nucleosomal DNA fragmentation in murine leukemic L1210 cells. Biochem Biophys Res Commun 194: 836-841, 1993.
11. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM, Zehnbauer BA, Hamilton SR and Jones RJ: Inhibition of apoptosis during development of colorectal cancer. Cancer Res 55:1811-1816, 1995.
12. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124: 1-6, 1994.
13. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462, 1995.
14. Barry MA, Behnke CA and Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 40: 2353-2362, 1990.
15. Nowell PC: The clonal evolution of tumor cell populations. Science 194:23-28, 1976.
16. Golombick T and Bezwada WR: In vitro maintenance of a new ovarian cancer cell line in protein-free madia: a potential model for autonomous crowth and tumor progression. Eur J Cell Biol 56:459-463, 1991.
17. Iihara K, Shiozaki H, Oku K, Tahara H, Doki Y, Oka H, Kadowaki T, Iwazawa T, Inoue M and Mori T: Growth-regulatory mechanism of two human esophageal-cancer cell lines in protein-free conditions. Int J Cancer 55:364-370, 1993.
18. Kath R, Jambrosic JA, Holland L, Rodeck U and Herlyn M: Development of invasive and growth factor-independent cell variants from primary human melanomas. Cancer Res 51: 2205-2211, 1991.
19. Okabe T, Fujisawa M and Takaku F: Long-term cultivation and differentiation of human erythroleukemia cells in a protein-free chemically defined medium. Proc Natl Acad Sci USA 81: 453-455, 1984.
20. Rodeck U, Herlyn M, Menssen HD, Furlanetto RW and Koprowski H: Metastatic but not primary melanoma cell lines grow in vitro independently of exogenous growth factors. Int J Cancer 40:687-690, 1987.
21. Williams NN, Györfi T, Iliopoulos D, Herlyn D, Greenstein D, Linnenbach AJ, Daly JM, Jensen P, Rodeck U and Herlyn M: Growth-factor-independence and invasive properties of colorectal carcinoma cells. Int J Cancer 50:274-280, 1992.
22. Watanabe H, Chigira M and Arita S: Murine fibrosarcoma clone established in defined medium. In Vitro Cell Dev Biol 27A: 267-269, 1991.
23. Watanabe H and Chigira M: The role of endogenous proteins in the protein-free maintenance of three distinct tumor cell lines in vitro. Int J Oncol 1:481-487, 1992.
24. Masuda Y, Yoshitake Y and Nishikawa K: Growth control of A431 cells in protein-free medium: secretory products do not affect cell growth. In Vitro Cell Dev Biol 24: 893-899, 1988.
25. Okabe T, Fujisawa M, Mihara A, Sato S, Fujiyoshi N and Takaku F: Growth factor(s) produced by a human leukemic cell line growing in a protein-free chemically defined medium. Cancer Res 46:1043-1046, 1986.
26. Watanabe H, Shinozaki T, Raz A and Chigira M: Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis. Int J Cancer 53:689-695, 1993.
27. Nabi IR, Watanabe H and Raz A: Identification of B 16-F1 melanoma autocrine motility-like factor receptor. Cancer Res 50: 409-414, 1990.
28. Watanabe H, Carmi P, Hogan V, Raz T, Silletti S, Nabi IR and Raz A: Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor. J Biol Chem 266: 13442-13448, 1991.
29. Watanabe H, Takehana K, Date M, Shinozaki T and Raz A: Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide. Cancer Res 56:2960-2963, 1996.
30. Watanabe H, Nabi IR and Raz A: The relationship between motility factor receptor internalization and the lung colonization capacity of murine melanoma cells. Cancer Res 51:2699-2705, 1991.
31. Watanabe H, Kanbe K, Shinozaki T and Chigira M: Apoptosis of a fibrosarcoma induced by protein-free culture involves DNA cleavage to large fragments but not internucleosomal fragmentation. Int J Cancer 62:191-198, 1995.
32. Pardee AB: G1 events and regulation of cell proliferation. Science 246: 603-608, 1989.
33. Tomei LD, Shapiro JP and Cope FO: Apoptosis in C3H/10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double-strand cleavage. Proc Natl Acad Sci USA 90: 853-857, 1993.
34. Evan GI and Hancock DC: Studies on the interaction of the human c-myc protein with cell nuclei: p62 c-myc as a member of a discrete subset of nuclear proteins. Cell 43: 253-261, 1985.
35. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 69:119-128, 1992.
36. Evan GI and Littlewood TD: The role of c-myc in cell growth. Curr Opin Genet Dev 3:44-49, 1993.
37. Degols G, Leonetti J-P, Mechti N and Lebleu B: Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene. Nucleic Acid Res 19:945-948, 1991.
38. cdc2 activation required for apoptosis. Science 263: 1143-1145, 1994.
39. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A and Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352: 345-347, 1991.
40. Hartwell LH and Kastan MB: Cell cycle control and cancer. Science 266:1821-1828, 1994.
41. Rawson C, Cosola-Smith C and Barnes D: Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation is prevented by cycloheximide, 12-O-tetradecanoylphorbol-13-acetate, or vanadate. Exp Cell Res 186: 177-181, 1990.
42. Tamm I and Kikuchi T: Activation of signal transduction pathways protects quiescent Balb/c-3T3 fibroblasts against death due to serum deprivation. J Cell Physiol 148: 85-95, 1991.
43. Filipski J, Leblanc J, Youdale T, Sikorska M and Walker PR: Periodicity of DNA folding in higher order chromatin structure. EMBO J 9:1319-1327, 1990.
44. Bicknell GR and Cohen GM: Cleavage of DNA to large kilobase pair fragments occurs in some forms of necrosis as well as apoptosis. Biochem Biophys Res Commun 207:40-47, 1995.
45. Brown DG, Sun X-M and Cohen GM: Dexamethasone-induced apoptosis involves cleavage of DNA to large fragments prior to internucleosomal fragmentation. J Biol Chem 268:3037-3039, 1993.
46. Zhivotovsky B, Wade D, Gahm A, Orrenius S and Nicotera P: Formation of 50 kbp chromatin fragments in isolated liver nuclei is mediated by protease and endonuclease activation. FEBS Lett 351: 150-154, 1994.
47. Oberhammer F, Wilson JW, Dive C, Morris ID, Hickman JA, Wakeling AE, Walker PR and Sikorska M: Apoptotic death in epithelial cells: cleavage of DNA to 300- and /or 50-kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J 12: 3679-3684, 1993.
48. Kanbe K and Watanabe H: Different types of DNA cleavage involved in osteosarcoma cell death. Int J Oncol 9:145-151, 1996.
49. Beere HM, Chresta CM, Alejo-Herberg A, Skladanowski A, Dive C, Larsen AK and Hickman JA: Investigation of the mechanism of higher order chromatin fragmentation observed in drug-induced apoptosis. Mol Pharmacol 47:986-996, 1995.
50. Gjertsen BT, Cressey LI, Ruchaud S, Houge G, Lanotte M and Doskeland SO: Multiple apoptotic death types triggered through activation of separate pathways by cAMP and inhibtors of protein phosphatases in one (IPC leukemia) cell line. J Cell Sci 107:3363-3377, 1994.
51. Sun X-M, Snowden RT, Skilleter SN, Dinsdale D, Ormerod MG and Cohen GM: A flow-cytometric method for the separation and quantitation of normal and apoptotic thymocytes. Anal Biochem 204:351-356, 1992.
52. Askew DS, Ashmun RA, Simmons BC and Cleveland JL: Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene 6: 1915-1922, 1991.
53. Norbury C and Nurse P: Animal cell cycles and their control. Annu Rev Biochem 61:441-470, 1992.
54. Prescott DM: Cell reproduction. Int Rev Cytol 100:93-128, 1987.
55. Graham CF and Morgan RW: Changes in cell cycle during early amphibian development. Dev Biol 14:439-460, 1966.
56. Newport JW and Kirschner MW: Regulation of the cell cycle during early Xenopus development. Cell 37:731-742, 1984.
57. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP and Green DR: Role for c-myc in activation-induced apoptotic cell death in T cell hybridoma. Science 257:212-214, 1992.
58. Amati B, Littlewood TD, Evan GI and Land H: (1993) The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J 16: 5038-5087, 1993.
59. Dean M, Levine RA, Ran W, Kindy MS, Sonenshein GE and Campisi J: Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem 261:9161-9166, 1986.
60. Waters CM, Littlewood TD, Hancock DC, Moore JP and Evan GI: c-myc protein expression in untransformed fibroblasts. Oncogene 6:797-805, 1991.
61. Dasso M and Newport JW: Completion of DNA replication is monitored by a feedback system that controls the initiation of mitosis in vitro: studies in Xenopus. Cell 61:811-823, 1990.
62. Martin SJ, McGahon AJ, Nishioka WK, Face DL, Guo X, Th'ng J, Bradbury EM and Green DR: p34cdc2 and apoptosis. Science 269: 106-107, 1995.
63. Cross SM, Sanchez CA, Morgan CA, Schimke MK, Ramel S, Idzerda RL, Raskind WH and Reid BJ: A p53-dependent mouse spindle checkpoint. Science 267: 1353-1356, 1995.
64. Lindenboim L, Diamond R, Rothenberg E and Stein R: Apoptosis induced by serum deprivation of PC cells is not preceded by growth arrest and can occur at each phase of the cell cycle. Cancer Res 55:1242-1247, 1995.
65. Linette GP, Li Y, Roth K and Korsmeyer SJ: Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA 93: 9545-9552, 1996.